Niki BiosolutionsNIKI
13F holders, Q1 2025 (March 31)8holders +4
4new positions
0sold out
$0.84avg. 13F price*
At the end of Q1 2025, 8 institutions reported holding Niki Biosolutions Inc. (NIKI) in their 13F filings, up 4 from Q4 2024. 4 opened new positions and 0 sold out. The largest holders were Geode Capital Management, LLC ($31K), Morgan Stanley ($18K) and Susquehanna International Group, LLP ($14K).
- Company
- Niki Biosolutions Inc.
- Filed as
- APTORUM GROUP LIMITED (Q1 2025)
- CUSIP
- G6096M122
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $28K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 48,043 shares bought and 1,510 shares sold, net +46,533 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Geode Capital Management, LLC | 0.00% | Reduce -3.8% | 36,947 | $31K |
| Morgan Stanley | 0.00% | Add +134.6% | 21,156 | $18K |
| Susquehanna International Group, LLP | 0.00% | New | 17,208 | $14K |
| XTX Topco Ltd | 0.00% | New | 10,039 | $8K |
| Osaic Holdings, Inc. | 0.00% | New | 5,500 | $5K |
| UBS Group AG | 0.00% | Add +1480.7% | 3,351 | $3K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -50.4% | 67 | $56 |
| Citigroup Inc. | 0.00% | New | 19 | $16 |
"% of holder's portfolio" is NIKI's weight in each manager's 13F, not the share of Niki Biosolutions Inc. the manager owns.